Andera Partners Participates in the €45 Million Series B Financing of Grey Wolf Therapeutics, led by Pfizer Ventures, to Advance First-of-its-Kind Neoantigen Creation Approaches
Destiny Pharma: US Center for Disease Control (CDC) and two major medical journals cite the importance of decolonization in preventing surgical site infections
Carbios and Novozymes strengthen collaboration with long-term exclusive strategic partnership to secure worldwide leadership in biorecycling of PET
Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatment of hypertension
Andera Partners participates in the $138 Million Series C Financing of Amolyt Pharma led by Sofinnova Partners and co-led by Intermediate Capital Group